Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent

OBJECTIVES: To compare the efficacy and safety of the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent (DTS) and the sirolimus‐eluting Orsiro stent (SES) in patients with and without diabetes mellitus (DM) included in the Scandinavian Organization for Randomized Trials with Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsen, Lars, Christiansen, Evald H., Freeman, Phillip, Kahlert, Johnny, Veien, Karsten, Maeng, Michael, Raungaard, Bent, Ellert, Julia, Kristensen, Steen D., Christensen, Martin K., Terkelsen, Christian J., Thim, Troels, Eftekhari, Ashkan, Jensen, Rebekka V., Støttrup, Nicolaj B., Junker, Anders, Hansen, Henrik S., Jensen, Lisette O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542312/
https://www.ncbi.nlm.nih.gov/pubmed/35384254
http://dx.doi.org/10.1002/ccd.30175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542312/
https://www.ncbi.nlm.nih.gov/pubmed/35384254
http://dx.doi.org/10.1002/ccd.30175

Ejemplares similares